Brief: Northwest Biotherapeutics files for mixed shelf offering - SEC filing
13/11/2015 11:05
Nov 13 (Reuters) - Northwest Biotherapeutics Inc NWBO.O : * Files for mixed shelf offering of up to $150 million - SEC filing * Source text for Eikon (http://1.usa.gov/1Mbpm5E) * Further company coverage NWBO.O ((Bengaluru Newsroom; +1 646 223 8780))
Recent news on Northwest Biotherapeutics
See all newsBrief: Northwest Biotherapeutics And The UK National Health Service Blood And Transplant Announce Collaboration To Support Dcvax®-L Production
Brief: Northwest Biotherapeutics Provides Update On Final Preparations For Marketing Authorization Application
Brief: Northwest Biotherapeutics Provides Update On Near Term Plans For Submission Of Marketing Authorization Application
Brief: Northwest Biotherapeutics And Advent Bioservices Announce Receipt Of License For Commercial Manufacturing At Sawston, U.K. Facility
Brief: Northwest Biotherapeutics Announces That It Has No Banking Relationship With SVB